Department of Radiology, Research Institute of Radiological Science, Yonsei University Health System, Seoul, South Korea.
Am J Surg. 2010 Jan;199(1):1-7. doi: 10.1016/j.amjsurg.2008.11.037. Epub 2009 May 1.
This study was conducted to evaluate the long-term follow-up results from ultrasound-guided vacuum-assisted removal (US-VAR) of palpable benign breast mass and to identify patient characteristics that are correlated with recurrence or residual lesions.
US-VAR was performed on 95 benign, palpable breast masses that underwent subsequent intervention or at least a 2-year follow-up. During the follow-up period, we reviewed the lesion and patient's characteristics, and then determined whether the presence of recurrence or residual lesions was associated with any of the characteristics.
Six lesions (6.3%) underwent subsequent intervention due to the recurrence of palpability. The remaining 89 lesions underwent imaging follow-up (range, 24 to 60 months; mean, 35 months). Among these lesions, 32.6% (31 of 95 masses) showed sonographically visible, nonpalpable residual lesions. The remaining 61.1% (58 masses) showed no evidence of residual lesion. The initial size of the lesion at VAR was the only characteristic correlated with recurrence (P = .017; odds ratio, 1.238).
Our long-term follow-up results show that US-VAR may be a useful alternative to surgical excision in the management of palpable breast masses.
本研究旨在评估超声引导下真空辅助切除（US-VAR）触诊良性乳腺肿块的长期随访结果，并确定与复发或残留病变相关的患者特征。
对 95 例经 US-VAR 治疗的触诊良性乳腺肿块进行后续干预或至少 2 年随访。在随访期间，我们回顾了病变和患者的特征，并确定了复发或残留病变是否与任何特征相关。
6 个病变（6.3%）因可触及的复发而进行了后续干预。其余 89 个病变进行了影像学随访（范围 24 至 60 个月；平均 35 个月）。这些病变中，32.6%（95 个肿块中的 31 个）出现了超声可见的、不可触及的残留病变。其余 61.1%（58 个肿块）未发现残留病变。VAR 时病变的初始大小是唯一与复发相关的特征（P =.017；优势比，1.238）。
我们的长期随访结果表明，US-VAR 可能是触诊乳腺肿块治疗的一种有用的手术切除替代方法。
